10-15 ASSOCIATES, INC. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
10-15 ASSOCIATES, INC. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$205,000
-28.8%
1,6700.0%0.04%
-33.9%
Q2 2019$288,000
+4.3%
1,670
+1.8%
0.06%
+5.1%
Q1 2019$276,000
+10.8%
1,640
+13.9%
0.06%
+5.4%
Q3 2018$249,000
+9.2%
1,440
-11.9%
0.06%
+9.8%
Q2 2018$228,0001,6350.05%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders